National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
October 30, 2012 • Volume 9 / Number 21


Study Urges Caution on Source of Unrelated Donor Stem Cell Transplants

Transplant recipient Teresa Hurtado-Diaz and her donor Lydia Gonzalez (Courtesy of the National Marrow Donor Program) The first randomized trial comparing bone marrow and peripheral blood stem cells (PBSCs) as sources for hematopoietic stem cell transplants from unrelated donors suggests that caution may be needed when using PBSCs from unrelated donors to treat leukemia or related blood disorders. The results were published October 18 in the New England Journal of Medicine. Read more > >


Dr. Edward Trimble

Building Momentum: NCI's Center for Global Health

Dr. Ted Trimble, director of NCI's Center for Global Health, discusses how the new center will work to reduce the global burden of cancer. video icon

Dr. Loehrer and young orphan

A Conversation with Dr. Patrick Loehrer about Improving Cancer Care in Kenya

The director of the Indiana University Melvin and Bren Simon Cancer Center describes a collaborative effort to establish a cancer program and treatment center at the Moi University School of Medicine in Eldoret, Kenya.



  • Notes

    • In Memoriam: Dr. E. Donnall Thomas
    • Board of Scientific Advisors to Meet November 5
    • Cyber-Seminar: Adapting and Using Evidence-Based Programs with Community Partners


Cancer Resources for Those Affected by Hurricane Sandy

Information is available to help cancer patients, physicians, and researchers who are in areas affected by recent storms.

Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >